How Omega-3 Fatty Acids Support Mental Health: A Clinical Summary

Omega-3 polyunsaturated fatty acids (PUFAs) — particularly EPA and DHA — integrate into neuronal membranes and influence nearly every aspect of brain function. Here is a clinical summary of the six key mechanisms through which they support mental health.

1. Reducing Neuroinflammation

Omega-3 PUFAs generate resolvins and protectins — specialised pro-resolving mediators that actively resolve microglial activation in the brain. Microglia are the brain’s immune cells; when chronically activated, they drive neuroinflammation implicated in depression, anxiety, and neurodegeneration. Omega-3s shift the neuroinflammatory environment from destructive to reparative.

2. HPA Axis Modulation

The HPA (Hypothalamus–Pituitary–Adrenal) axis governs the body’s stress response. Omega-3 supplementation has been shown to normalise cortisol secretion under stress conditions, reducing the physiological burden of the stress response and improving long-term stress resilience.

3. Enhanced Antioxidant Defence

Through Nrf2-mediated enzyme induction, omega-3 fatty acids upregulate the brain’s endogenous antioxidant systems, protecting neurons from oxidative injury. This is particularly relevant in conditions characterised by elevated oxidative stress — including chronic depression and anxiety disorders.

4. BDNF Upregulation and Synaptic Plasticity

Omega-3s promote production of BDNF (brain-derived neurotrophic factor) and support synaptic plasticity — the brain’s ability to form new connections. Higher BDNF correlates with better learning, memory, and mood regulation. Low BDNF is a consistent finding in depression.

5. Depression — EPA-Dominant Supplementation

EPA-dominant supplements at ≥1 g/day have been shown across multiple trials and meta-analyses to significantly alleviate depressive symptoms — both as monotherapy and as an adjunct to SSRIs. Higher EPA:DHA ratios produce the most consistent effects. Benefits are strongest in those with low baseline omega-3 status.

6. Anxiety — Combined EPA+DHA

Combined EPA+DHA intakes of approximately 2 g/day yield moderate reductions in anxiety symptoms across dose-response meta-analyses. This dose range shows optimal efficacy with minimal risk of adverse effects, making it a practical and evidence-supported recommendation.

Key Clinical Parameters

• EPA-dominant formulation: EPA:DHA ratio ≥ 2:1 for mood and depression applications
• Combined EPA+DHA for anxiety: approximately 2 g/day
• Duration: minimum 8–12 weeks for measurable clinical benefit
• Greatest benefit: individuals with low baseline omega-3 status

Safety profile: excellent — minimal adverse effects at recommended doses